EWEN V. DOLLE et al. - Page 94




          Interference 103,482                                                        
          Angstadt first instructs at 537 F.2d at 501, 190 USPQ at 217:               
                    . . . [T]he claim limitation “to form * * *                       
               hydroperoxides” must be given effect since we must give                
               effect to all claim limitations.  See In re Geerdes,                   
               491 F.2d 1260, 180 USPQ 789 (Cust. & Pat. App. 1974); In               
          re Wilder, 429 F.2d 447, 57 CCPA 1314, 166 USPQ 545 (1970).                 
          Similarly, we must give effect to the phrase “for the                       
          preparation of a syndio-isoblock polymer having molecular                   
          chains in which syndiotactic and isotactic sequences are                    
          present and the sequence length is 3 to 50 monomer units” as a              
          functional limitation of Dolle’s claims.  That is, even if                  
          Dolle’s claims could be broadly interpreted to read on                      
          processes for homopolymerizing ethylene or any other                        
          symmetrical olefin without a 1-olefin comonomer, persons                    
          skilled in the art immediately would have understood from                   
          Dolle’s disclosure that the processes claimed include only                  
          those processes for producing polymers from olefin monomers                 
          which may be polymerized to form syndio-isoblock polymers                   
          having molecular chains in which syndiotactic and isotactic                 
          sequences are present.  “There is nothing intrinsically wrong               
          in defining something by what it does rather than what it is.”              
          In re Echerd, 471 F.2d 632, 635, 176 USPQ 321, 322-23 (CCPA                 
          1973).                                                                      



                                         94                                           





Page:  Previous  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  Next 

Last modified: November 3, 2007